Warning!
Your browser does not support HTML5.
Display of the content may be incorrect.
Please make sure that your browser supports HTML5 syntax.
Structure Info
- Chemspace ID
- CSSS00132334265 (In-Stock Screening Compounds)
- MFCD
- MFCD00420048
- IUPAC Name
1-(4-bromophenyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline
- Mol formula
- C17H18BrNO2
- Mol weight
- 348 Da
- Catalog Number(s)
5118443, 5137158, CD11002309, CSC132334265, HAA47399, OSSL_046601, STK324751, WDA31584, ZX-AX000323
Properties
- LogP
- 3.81
- Heavy atoms count
- 21
- Rotatable bond count
- 3
- Number of rings
- 3
- Carbon bond saturation, Fsp3
- 0.294
- Polar surface area (Å)
- 30
- Hydrogen bond acceptors count
- 3
- Hydrogen bond donors count
- 1
Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
Princeton Biomolecular Research | 10 days | United States To: | 90 | 1 mg | 88 | |
Princeton Biomolecular Research | 10 days | United States To: | 90 | 2 mg | 94 | |
Princeton Biomolecular Research | 10 days | United States To: | 90 | 5 mg | 99 | |
Princeton Biomolecular Research | 10 days | United States To: | 90 | 10 mg | 116 | |
Princeton Biomolecular Research | 10 days | United States To: | 90 | 15 mg | 132 | |
Princeton Biomolecular Research | 10 days | United States To: | 90 | 20 mg | 143 | |
Princeton Biomolecular Research | 10 days | United States To: | 90 | 50 mg | 231 | |
Princeton Biomolecular Research | 10 days | United States To: | 90 | 100 mg | 297 | |
Princeton Biomolecular Research | 10 days | United States To: | 90 | 3 umol | 94 | |
Princeton Biomolecular Research | 10 days | United States To: | 90 | 5 umol | 99 | |
Show all items |
ChemBridge Corp. | 14 days | United States To: | 90 | 1 mg | 68 | |
ChemBridge Corp. | 14 days | United States To: | 90 | 5 mg | 99 | |
Description: Name: 1-(4-bromophenyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline; Stereochemistry: unknown; Compound state: solid | |
Show all items |
For a custom pack size or bulk
please drop us a line:
Enquire
Title
By using our site chem-space.com
you agree to our use of cookies to enhance your experience.
See the Privacy Policy for more information.
OK